Skip to main content
. 2014 May 21;2014:371087. doi: 10.1155/2014/371087

(b)

Partial response Stable disease Progressive disease
DAC Malignant pleural tumor Colorectal adenocarcinoma
Esophageal adenocarcinoma
Alveolar carcinoma
Intrahepatic bile ducts adenocarcinoma
Hepatocellular carcinoma
Gastric cancer

DAC + chemo Ovary carcinoma
Lung adenocarcinoma
Tubal serous adenocarcinoma
Lung adenocarcinoma
Cardia adenocarcinoma
Hodgkin's lymphoma
Non-Hodgkin's lymphoma
Cervical squamous cell carcinomas
Lung adenocarcinoma
Small cell carcinoma of the esophagus
Esophageal squamous cell carcinomas
Colon adenocarcinoma
Non-Hodgkin's lymphoma

DAC + CIK Pancreatic cancer
Hepatocellular carcinoma
Hepatocellular carcinoma

Note. CIK: cytokine induced killer cells; DAC + chemo: decitabine in combination with chemotherapy; DAC + CIK: decitabine in combination with CIK.